Vor Biopharma
(NASDAQ) VOR
Vor Biopharma Financials at a Glance
Market Cap
$1.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$883.08M
EPS (TTM)
-$333.48
P/E Ratio
-0.06
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$19.77
Volume
109
Open
$20.17
Price
$19.77
Volume
109
Open
$20.17
Previous Close
$19.75
Daily Range
$19.45 - $20.95
52-Week Range
$6.50 - $56.80
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$19.77
Volume
109
Open
$20.17
Previous Close
$19.75
Daily Range
$19.45 - $20.95
52-Week Range
$6.50 - $56.80
Estimated Earnings Date
Aug 11, 2026
VOR News
VOR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vor Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
76
CEO
Jean-Paul Kress, MD
Website
www.vorbio.comHeadquarters
Cambridge, MA 02140, US
VOR Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
87.31%
Return on Capital
N/A
Return on Assets
-174.26%
Earnings Yield
-16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
54.19M
Volume
109
Avg. Volume
1.19M
Financials (TTM)
Gross Profit
-$28.00K
Operating Income
-$373.51M
EBITDA
$449.13M
Operating Cash Flow
-$149.89M
Capital Expenditure
-$758.00K
Free Cash Flow
-$150.65M
Cash & ST Invst.
$491.53M
Total Debt
$2.94M
Vor Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$28.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.07BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$14.08M
N/A
Employees
76
N/A
Net Income
-$219.59M
-575.9%
EBITDA
-$219.56M
-593.5%
Quarterly Fundamentals
Total Cash
$491.53M
+718.7%
Total Debt
$2.94M
-90.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$2.63M
-90.1%
Short Term Debt
$307.00K
-92.8%
Return on Assets
-1.74%
N/A
Return on Invested Capital
-76.12%
N/A
Free Cash Flow
-$38.29M
-22.4%
Operating Cash Flow
-$38.25M
-23.1%